Artemis Medicare Services Limited — Others, 07-07-2025: Shareholders meeting

Artemis Medicare Services Limited reported strong operational and financial growth in FY 2024-25, with revenue from operations rising to Rs. 913.26 Cr standalone and Rs. 936.92 Cr consolidated, driven by capacity expansion including the inauguration of its third tower. EBITDA improved significantly to Rs. 182.76 Cr standalone and Rs. 184.78 Cr consolidated, with net profit doubling to Rs. 83.46 Cr and Rs. 82.18 Cr respectively. The company raised Rs. 330 Cr through compulsorily convertible debentures (CCDs) from International Finance Corporation to fund quaternary and super-specialty care expansions. It entered a long-term management agreement for a 300+ bed super-specialty hospital in Raipur and launched advanced physiotherapy services with ABTP. Artemis is upgrading its Hospital Information System for enhanced efficiency and exploring AI integration to improve clinical outcomes and patient engagement. The Board has recommended a final dividend of Re. 0.45 per share. The company maintains rigorous governance standards, with no material regulatory issues reported, and compliance certifications in place. Key risks include regulatory changes, talent availability, cybersecurity, and operational costs, while opportunities lie in rising insurance penetration, medical value travel, and digital health adoption. The subsidiary, Artemis Cardiac Care Pvt Ltd, reported a loss before tax of Rs. 1.59 Cr. Internal controls were deemed adequate and effective, with statutory auditors issuing an unqualified opinion.